Beta Blocker Treatment in Hemangiomas: Experience in 344 Cases in A Single Institute

dc.contributor.authorYazici, N.
dc.contributor.authorSarialioglu, F.
dc.contributor.authorErbay, A.
dc.contributor.authorErdogan, I.
dc.contributor.authorMisirlioglu, P. Kiper
dc.contributor.orcIDhttps://orcid.org/0000-0002-8257-810Xen_US
dc.contributor.orcIDhttps://orcid.org/0000-0001-6887-3033en_US
dc.contributor.researcherIDAAM-5138-2021en_US
dc.contributor.researcherIDAAL-7766-2021en_US
dc.contributor.researcherIDABB-2220-2021en_US
dc.date.accessioned2023-12-20T12:23:12Z
dc.date.available2023-12-20T12:23:12Z
dc.date.issued2014
dc.identifier.endpage356en_US
dc.identifier.issn1545-5009en_US
dc.identifier.startpage356en_US
dc.identifier.urihttp://hdl.handle.net/11727/11146
dc.identifier.volume61en_US
dc.identifier.wos000343932101120en_US
dc.language.isoengen_US
dc.relation.journalPEDIATRIC BLOOD & CANCERen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleBeta Blocker Treatment in Hemangiomas: Experience in 344 Cases in A Single Instituteen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: